Back to search

Article

Immune-Related Genes for the Prediction of Response to Imatinib therapy in Chronic Myeloid Leukemia

2023-07-05

Abstract excerpt

<h4>Background: </h4> Chronic myeloid leukemia (CML) is a malignant hyperplastic tumor that originates from pluripotent hematopoietic stem cells in the bone marrow. The introduction of tyrosine kinase inhibitors (TKIs) has significantly enhanced the survival rate of CML patients. This study aimed to identify immune-related genes (IRGs) associated with the response to imatinib therapy in CML. Methods. We obtained g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa0f935c-e0de-5e33-a7d1-532151e223e8
DOI
10.21203/rs.3.rs-3124281/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immune-Related Genes for the Prediction of Response to Imatinib therapy in Chronic Myeloid LeukemiaDOI 10.21203/rs.3.rs-3124281/v1
Select a neighboring publication to make it the new centre.